Načítá se...
Modern approaches to accelerate discovery of new anti-schistosomal drugs
INTRODUCTION: The almost exclusive use of only praziquantel for the treatment of schistosomiasis has raised concerns about the possible emergence of drug-resistant schistosomes. Consequently, there is an urgent need for new anti-schistosomal drugs. The identification of leads and the generation of h...
Uloženo v:
| Vydáno v: | Expert Opin Drug Discov |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534417/ https://ncbi.nlm.nih.gov/pubmed/27073973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17460441.2016.1178230 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|